E-LIB Suche - Ergebnisse für: Marshall, Scott

1

Molecular MRD is strongly prognostic in patients with NPM1-..:

Othman, Jad ; Tiong, Ing S. ; O'Nions, Jenny...
Blood. 143 (2024) 4 - p. 336-341 , 2024

Link: https://doi.org/10.1182/..

2

RNA Sequencing Reveals Candidate Genes and Pathways Associa..:

Aptullahoglu, Erhan ; Nakjang, Sirintra ; Wallis, Jonathan P....
Biomedicines. 12 (2024) 7 - p. 1388 , 2024

Link: https://doi.org/10.3390/..

3

Prediction of relative change in free nerve growth factor f..:

Shoji, Satoshi ; Suzuki, Akiyuki ; Nouri, Parya...
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 9 - p. 1358-1370 , 2023

Link: https://doi.org/10.1002/..

4

Model‐Informed Drug Development: Steps Toward Harmonized Gu..:

Marshall, Scott ; Ahamadi, Malidi ; Chien, Jenny...
Clinical Pharmacology & Therapeutics. 114 (2023) 5 - p. 954-959 , 2023

Link: https://doi.org/10.1002/..

5

SF3B1 Mutations Are Associated with Resistance to Non-Genot..:

Aptullahoglu, Erhan ; Wallis, Jonathan P. ; Marr, Helen...
International Journal of Molecular Sciences. 24 (2023) 14 - p. 11335 , 2023

Link: https://doi.org/10.3390/..

6

Splicing Modulation Results in Aberrant Isoforms and Protei..:

Aptullahoglu, Erhan ; Ciardullo, Carmela ; Wallis, Jonathan P....
International Journal of Molecular Sciences. 24 (2023) 3 - p. 2410 , 2023

Link: https://doi.org/10.3390/..

7

Teleneurocritical Care for Patients with Large Vessel Occlu..:

Murray, Nick M. ; Marshall, Scott ; Hoesch, Robert...
Neurocritical Care. 38 (2022) 3 - p. 650-656 , 2022

Link: https://doi.org/10.1007/..

8

The safety and clinical effectiveness of rapid infusion wit..:

Bishton, Mark ; Marshall, Scott ; Harchowal, Jatinder...
Hematological Oncology. 40 (2022) 3 - p. 370-380 , 2022

Link: https://doi.org/10.1002/..

9

Real‐world clinical effectiveness and safety of CT‐P10 in p..:

Bishton, Mark J. ; Salles, Gilles ; Golfier, Camille...
eJHaem. 4 (2022) 1 - p. 45-54 , 2022

Link: https://doi.org/10.1002/..

10

Allogenic haematopoeitic stem cell transplant as cure for s..:

Ramanathan, Subramaniam ; Roberts, Wing ; Carey, Peter...
Pediatric Blood & Cancer. 70 (2022) 2 - p. , 2022

Link: https://doi.org/10.1002/..

11

Population pharmacokinetics of tanezumab following intraven..:

Shoji, Satoshi ; Suzuki, Akiyuki ; Gaitonde, Puneet..
British Journal of Clinical Pharmacology. 88 (2022) 7 - p. 3321-3334 , 2022

Link: https://doi.org/10.1111/..

12

Low BACH2 Expression Predicts Adverse Outcome in Chronic Ly..:

Ciardullo, Carmela ; Szoltysek, Katarzyna ; Zhou, Peixun...
Cancers. 14 (2021) 1 - p. 23 , 2021

Link: https://doi.org/10.3390/..

13

Genome-wide association study identifies risk loci for prog..:

Lin, Wei-Yu ; Fordham, Sarah E. ; Sunter, Nicola...
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

14

Real‐world tyrosine kinase inhibitor treatment pathways, mo..:

Milojkovic, Dragana ; Cross, Nicholas C. P. ; Ali, Sahra...
British Journal of Haematology. 192 (2020) 1 - p. 62-74 , 2020

Link: https://doi.org/10.1111/..

15

Best Practice Approach to Successful Conversion of Fosaprep..:

Burns, Derek ; Kula, Julianna ; Marshall, Scott..
Advances in Therapy. 37 (2020) 7 - p. 3265-3277 , 2020

Link: https://doi.org/10.1007/..